At this year’s Charing Cross (CX) Symposium (23–25 April, London, UK), two leading figures in the endovascular aneurysm repair (EVAR) field—Andrew Holden (Auckland City Hospital, Auckland, New Zealand) and Dai Yamanouchi (University of Wisconsin, Madison, USA)—sat down to discuss the potential benefits of active sac management with the investigational IMPEDE-FX RapidFill device, remarking that sac shrinkage is key for a long term, durable EVAR procedure
This video is sponsored by Shape Memory Medical. LIT1199
